GlassScriptPhysician profile
Steven D Mottl
NPI 1104003748
$339,548.09
in general payments reported to CMS, 2019-2025
38 companies · $44K in 2025
The $44K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $22K · 2021: $27K · 2022: $40K · 2023: $47K · 2024: $99K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $162K · Travel and Lodging: $21K · Food and Beverage: $7,038 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $162,125.00 |
| Travel and Lodging | $21,076.23 |
| Food and Beverage | $7,037.63 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $328,099.27 | 2019-2025 | Definity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,185.70 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $915.25 | 2019-2025 | |
| Heartflow, INC. | $822.42 | 2019-2023 | Ffrct |
| Pfizer INC. | $708.03 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $569.58 | 2021-2025 | Verquvo |
| Amgen INC. | $446.96 | 2019-2023 | Repatha |
| Astellas Pharma US INC | $379.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $302.82 | 2019-2024 | |
| Esperion Therapeutics, INC. | $288.40 | 2020-2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $200.21 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $170.97 | 2019-2022 | |
| Novo Nordisk INC | $140.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Actelion Pharmaceuticals US, INC. | $135.23 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Pharmaceuticals, INC. | $122.81 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $102.96 | 2021-2024 | Farxiga |
| Endologix LLC | $100.98 | 2024 | Torus Stent Graft System, Endocross Device |
| Kestra Medical Technology Services, INC. | $93.50 | 2025 | Assure Wcd |
| Philips North America LLC | $93.49 | 2023-2025 | Extended Holter, (Ck7) Extended Holter |
| Abbott Laboratories | $86.01 | 2020-2023 | Aveir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.28 | 2022-2024 | Jardiance |
| Amarin Pharma, INC. | $69.08 | 2021-2022 | |
| Inspire Medical Systems, INC. | $60.67 | 2023-2025 | Inspire |
| Medtronic, INC. | $51.87 | 2021-2025 | Symplicity G3 |
| Alnylam Pharmaceuticals INC. | $41.20 | 2021 | |
| Irhythm Technologies, INC. | $38.99 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Medicomp INC | $31.74 | 2023 | Telepatch Cardiac Monitor |
| Abiomed | $30.00 | 2023 | Impella |
| Daiichi Sankyo INC. | $27.77 | 2023 | Injectafer |
| Boston Scientific Corporation | $25.98 | 2024 | Latitude Communicator Power Supply |
| Lexicon Pharmaceuticals, INC. | $20.91 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $18.06 | 2024 | Arcalyst |
| Cvrx, INC. | $15.48 | 2025 | Barostim Neo System |
| Atricure, INC. | $15.11 | 2019 | |
| Scpharmaceuticals INC. | $13.96 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $13.50 | 2023 | Arcalyst |
| Angiodynamics, INC. | $11.87 | 2021 | |
| Siemens Medical Solutions USA, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mottl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.